Berkley Life Sciences and Wilson Elser would like to invite you to a live webinar titled, “The FDA’s New Regulatory Scheme for Laboratory Developed Tests

posted in General Update

Berkley Life Sciences and Wilson Elser would like to invite you to a live webinar titled, "The FDA’s New Regulatory Scheme for Laboratory Developed Tests (LDT)", to be held on Tuesday, April 5th at 2 p.m. (EDT). 

Genese Dopson, Partner at Wilson Elser and a member of Berkley Life Sciences' Elite Defense Network, and Jae H. Lee, of Counsel at Wilson Elser, will discuss the two new FDA Draft Guidances concerning laboratory developed tests as well as their potential litigation impact.

Register now to learn how this change will impact your company and the broader life science industry.